Bbva Compass Bancshares Inc. cut its stake in shares of Varian Medical Systems, Inc. (NYSE:VAR) by 0.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 55,296 shares of the medical equipment provider’s stock after selling 37 shares during the period. Bbva Compass Bancshares Inc. owned about 0.06% of Varian Medical Systems worth $5,706,000 as of its most recent filing with the SEC.

Several other large investors have also recently modified their holdings of VAR. Park Avenue Securities LLC increased its stake in shares of Varian Medical Systems by 0.4% in the second quarter. Park Avenue Securities LLC now owns 2,276 shares of the medical equipment provider’s stock valued at $234,000 after buying an additional 9 shares in the last quarter. FineMark National Bank & Trust increased its stake in shares of Varian Medical Systems by 142.2% in the second quarter. FineMark National Bank & Trust now owns 5,744 shares of the medical equipment provider’s stock valued at $593,000 after buying an additional 3,372 shares in the last quarter. Parkwood LLC purchased a new stake in shares of Varian Medical Systems during the second quarter valued at approximately $437,000. Personal Capital Advisors Corp increased its stake in shares of Varian Medical Systems by 171.0% in the second quarter. Personal Capital Advisors Corp now owns 29,259 shares of the medical equipment provider’s stock valued at $3,019,000 after buying an additional 18,464 shares in the last quarter. Finally, Russell Investments Group Ltd. increased its stake in shares of Varian Medical Systems by 19.0% in the second quarter. Russell Investments Group Ltd. now owns 657,329 shares of the medical equipment provider’s stock valued at $67,864,000 after buying an additional 104,891 shares in the last quarter. Institutional investors own 99.27% of the company’s stock.

Varian Medical Systems, Inc. (NYSE:VAR) traded up 1.13% on Friday, hitting $97.74. The company had a trading volume of 812,205 shares. Varian Medical Systems, Inc. has a 12-month low of $75.20 and a 12-month high of $107.08. The firm has a 50-day moving average price of $101.70 and a 200-day moving average price of $93.39. The firm has a market capitalization of $8.97 billion, a PE ratio of 32.17 and a beta of 0.61.

Varian Medical Systems (NYSE:VAR) last issued its earnings results on Wednesday, July 26th. The medical equipment provider reported $1.04 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.95 by $0.09. The business had revenue of $662.40 million during the quarter, compared to the consensus estimate of $663.86 million. Varian Medical Systems had a return on equity of 24.70% and a net margin of 9.50%. The firm’s revenue for the quarter was up 3.0% on a year-over-year basis. During the same period in the previous year, the company posted $1.00 earnings per share. On average, equities research analysts anticipate that Varian Medical Systems, Inc. will post $3.94 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This article was originally posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this article on another domain, it was stolen and republished in violation of United States and international copyright and trademark law. The original version of this article can be read at https://theolympiareport.com/2017/08/12/bbva-compass-bancshares-inc-has-5-71-million-position-in-varian-medical-systems-inc-nysevar-updated.html.

Several brokerages have recently commented on VAR. BidaskClub upgraded shares of Varian Medical Systems from a “sell” rating to a “hold” rating in a research note on Saturday. Robert W. Baird restated a “neutral” rating and issued a $99.00 target price (up previously from $89.00) on shares of Varian Medical Systems in a research note on Friday, July 14th. Zacks Investment Research downgraded shares of Varian Medical Systems from a “buy” rating to a “hold” rating in a research note on Thursday, July 13th. Aegis restated a “hold” rating and issued a $91.00 target price on shares of Varian Medical Systems in a research note on Wednesday, May 17th. Finally, Goldman Sachs Group, Inc. (The) began coverage on shares of Varian Medical Systems in a research note on Tuesday, May 16th. They issued a “neutral” rating and a $92.00 target price on the stock. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of $96.28.

In other news, SVP John W. Kuo sold 863 shares of the business’s stock in a transaction that occurred on Monday, June 12th. The stock was sold at an average price of $101.25, for a total transaction of $87,378.75. Following the completion of the sale, the senior vice president now owns 28,224 shares in the company, valued at $2,857,680. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, SVP John W. Kuo sold 19,819 shares of the business’s stock in a transaction that occurred on Wednesday, May 31st. The shares were sold at an average price of $99.67, for a total value of $1,975,359.73. Following the sale, the senior vice president now owns 47,180 shares of the company’s stock, valued at approximately $4,702,430.60. The disclosure for this sale can be found here. Over the last quarter, insiders sold 158,284 shares of company stock valued at $16,022,132. 0.91% of the stock is currently owned by corporate insiders.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.